The Evolving Therapeutic Landscape of Multiple Myeloma in Canada – Webinar

Speaker: Dr. Alissa Visram, Hematologist, The Ottawa Hospital. Assistant Professor

Learning Objectives

• Review practise changing updates in myeloma over the last year
  Discuss how updates apply within the Canadian context
  Review therapies that are on the horizon in Canada

Accreditation: This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists (CAP-AC). You may claim a maximum of 1.0 hours. Certificates of Attendance will be sent to all CHS members who participate.

This on-demand video is supported by a grant from J&J Innovative Medicine.  The CHS Scientific Planning Committee has planned it to achieve scientific integrity, objectivity and balance.

Scientific Planning Committee

Dr. Pallavi Ganguli – Resident Physician, Hematology
Danyal Ladha – Resident Physician, Hematology
Dr. Joanne Britto – Clinical Hematologist
Dr. Yan Xu – Fellow Physician, Hematology/Thrombosis
Dr. Siraj Mithoowani – Clinical Hematologist at St. Joseph’s Healthcare, Hamilton
Dr. Hassan Sibai – Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician,
Division of Medical Hematology & Oncology, Princess Margaret Cancer Centre

Conflict of Interest: SPC None

Conflict of Interest Speaker -Honoraria and Consulting Fees/Advisory Board – Janssen, Forus, Pfizer, Sanofi

Collaborative Grant: Janssen